Redx Pharma is a drug discovery and development company formed in September 2010. It is focused on improving the characteristics of existing drug classes to create best-in-class new drugs in two main areas, cancer and infectious disease. The company's work has been endorsed by partnerships with global pharmaceutical companies and the NHS.
Redx Pharma has two subsidiaries: Redx Oncology Ltd launched in April 2012 and Redx Anti-Infectives Ltd launched in April 2013.
Revenue (FY, 2017)
Net income (FY, 2017)
EBITDA (FY, 2017)
EBIT (FY, 2017)
Market capitalization (24-May-2017)
Closing share price (24-May-2017)